In vitro and in vivo evaluation of the influence of type III NaPi co-transporter activity during apoptosis on 99mTc-(V)DMSA uptake in the human leukaemic cell line U937

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 10, 2004, Pages 1421-1427

  Denoyer, Delphine ^a,b   Perek, Nathalie ^a   Le Jeune, Nathalie ^a   Frere, Delphine ^a   Sabido, Odile ^b   Clotagatide, Anthony ^a   Dubois, Francis ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

Author keywords

99mTc (V)DMSA; Animal model; Apoptosis; Phosphate; Type III NaPi co transporters

Indexed keywords

COMPLEMENTARY DNA; COTRANSPORTER; ETOPOSIDE; FLUORESCEIN; LIPOCORTIN 5; MESSENGER RNA; PHOSPHATE; PROTEIN NPT1; SODIUM; SUCCIMER TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL METABOLISM; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUDE MOUSE; PHOSPHATE TRANSPORT; POLYMERASE CHAIN REACTION; SODIUM TRANSPORT; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; HUMANS; LEUKEMIA; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; SYMPORTERS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TISSUE DISTRIBUTION;

EID: 5444267305     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1605-y     Document Type: Article

References (40)

1. m-tetrofosmin. Nucl Med Commun 1999;20:353-9
2. m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Commun 1988;9:105-116
3. 99mTc-sestamibi in the assessment of histological type and grade in breast cancer. Nucl Med Commun 2002;23:461-67
4. Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging correlation with histology and malignant grade. J Nucl Med 1997;38:1741-49
5. Atasever T, Gundogdu C, Vural G, Kapucu LO, Karalezli A, Unlu M. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers. Nuklear-medizin 1997;36:223-7
6. 99mTc-(V)-DMSA uptake is mediated by NaP1 cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 2004;31:77-84
7. Ghishan FK, Rebeiz R, Honda T, Nakagawa N. Characterization and expression of a novel Na(+)-inorganic phosphate transporter at the liver plasma membrane of the rat. Gastroenterology 1993;105:519-26
8. Li H, Xle Z. Molecular cloning of two rat Na+/P1 cotransporters: evidence for differential tissue expression of transcripts. Cell Mol Biol Res 1995;41:451-60
9. Biber J, Custer M, Magagnin S, Hayes G, Werner A, Lotscher M, Kaissling B, Murer H. Renal Na/P1-cotransporters. Kidney Int 1996;49:981-5
10. Hisano S, Haga H, Li Z, Tatsumi S, Miyamoto KI, Takeda E, Fukui Y. Immunohistochemical and RT-PCR detection of Na+-dependent inorganic phosphate cotransporter (NaPi-2) in rat brain. Brain Res 1997;772:149-55
11. Gupta A, Miyauchi A, Fujimori A, Hruska KA. Phosphate transport in osteoclasts: a functional and immunochemical characterization. Kidney Int 1996;49:968-74
12. Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A 1998;95:14564-9
13. Kavanaugh MP, Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int 1996;49:959-63
14. Uckert W, Willimsky G, Pedersen FS, Blankenstein T, Pedersen L. RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther 1998;9:2619-27
15. Werner A, Dehmelt L, Nalbant P. Na+-dependent phosphate cotransporters: the NaPi protein families. J Exp Biol 1998;201:3135-42
16. Davis PK, Johnson GV. Energy metabolism and protein phosphorylation during apoptosis. a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells. Biochem J 1999;340:51-8
17. Wotawa A, Solier S, Logette E, Solary E, Corcos L. Differential influence of etoposide on two caspase-2 mRNA isoforms in leukemic cells. Cancer Lett 2002;185:181-9
18. Fernandes I, Beliveau R, Friedlander G, Silve C. NaPO(4) cotransport type III (PiT1) expression in human embryonic kidney cells and regulation by PTH. Am J Physiol 1999;277:F543-51
19. Shen MR, Wilkins RJ, Chou CY, Ellory JC. Anion exchanger isoform 2 operates in parallel with Na(+)/H(+) exchanger isoform 1 during regulatory volume decrease of human cervical cancer cells. FEBS Lett 2002;512:52-8
20. 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue. Nucl Med Commun 2003;24:1175-83
21. Filomenko R, Poirson-Bichat F, Billerey C, Belon JP, Garrido C, Solary E, Bettaieb A. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer Res 2002;62:1815-21
22. Horiuchi K, Saji H, Yokoyama A. Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis. Nucl Med Biol 1998;25:549-55
23. Lam ASK, Puncher MR, Blower PJ. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid. Eur J Nucl Med 1996;23:1575-82
24. Watkinson JC, Allen SJ, Laws DE, Lazarus CR, Maisey MN, Clarke SE. The pharmacokinetics and biodistribution of technetium-99m(V)dimercaptosuccinic acid in an animal tumor model. J Nucl Med 1991;32:1235-38
25. Blower PJ, Singh J, Clarke SE. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 1991;32:845-9
26. Ho AD, Lipp T, Ehninger G, Illiger HJ, Meyer P, Freund M, Hunstein W. Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia-an active and well-tolerated regimen. J Clin Oncol 1988;6:213-7
27. Athanasoulis T, Koutsikos J, Moulopoulos LA, Tsiouris S, Dimopoulos MA, Zerva C. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy. Clin Nucl Med 2003;28:631-5
28. 99mTc-radiolabeled annexin V. J Nucl Med 2001;42:309-16
29. McGill G, Fisher DE. Apoptosis in tumorigenesis and cancer therapy. Front Biosci 1997;2:353-79
30. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging 2003;30:615-30
31. 99mTc-annexin V. J Nucl Med 2003;44:92-7
32. Blankenberg FG, Tait J, Ohtsuki K, Strauss HW. Apoptosis: the importance of nuclear medicine. Nucl Med Commun 2000;21:241-50
33. Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, Enne W, Herz M, Nerl C, Garbrecht M, Schwaiger M. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 1998;91:4464-71
34. 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003;39:2012-20
35. Simo M, Lomena F, Setoam J, Perez G, Castellucci P, Costansa JM, Setoain-Quinquer J, Domenech-Torne F, Carrió I. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun 2002;23:975-82
36. Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up. Eur J Nucl Med 2001;28:304-12
37. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities. Q J Nucl Med 2003;47:51-7
38. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995;34:12210-20
39. Perek N, Koumanov F, Denoyer D, Boudard D, Dubois F. Modulation of the multidrug resistance of glioma by glutathione levels depletion-interaction with Tc-99m-sestamibi and Tc-99m-tetrofosmin. Cancer Biother Radiopharm 2002;17:291-302
40. Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic acid uptake. Cancer Biother Radiopharm 2003;18:791-801